VXc-0522

N/A

Report date: 2023/03/04 19:34:02
NME

Base Information

Drug NameVXc-0522
Drug Alias NamemRNAs coding for the CFTR proteinVXc-0522VXc-522
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionProtein synthesis stimulantsCFTR gene transference
TargetsCystic fibrosis transmembrane conductance regulator
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesModerna Inc
China Registration ClassN/A

Develop Information

Active CompaniesModerna IncVertex Pharmaceuticals Incorporated
Inactive CompaniesN/A
Active IndicationsCystic Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A